Effect of occult metastases on survival in node-negative breast cancer

New England Journal of Medicine

Volumn 364, Issue 5, 2011, Pages 412-421

  Weaver, Donald L ^a,b   Ashikaga, Takamaru ^a,b   Krag, David N ^a,b   Skelly, Joan M ^a   Anderson, Stewart J ^b,c   Harlow, Seth P ^a,b   Julian, Thomas B ^b,d   Mamounas, Eleftherios P ^b,e   Wolmark, Norman ^b,d  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b NSABP Foundation Inc   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d ALLEGHENY GENERAL HOSPITAL   (United States)

^e Aultman Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SURVIVAL; CLINICAL DECISION MAKING; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OCCULT LYMPH NODE METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE BIOPSY; SINGLE BLIND PROCEDURE; TISSUE LEVEL; TUMOR VOLUME;

EID: 79551566712     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1008108     Document Type: Article

References (18)

1. Saphir O, Amromin GD. Obscure axillary lymph node metastases in carcinoma of the breast. Cancer 1948;1:238-41.
2. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997;80:1188-97.
3. de Boer M, van Dijck JA, Bult P, Borm GF, Tjan-Heijnen VC. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst 2010;102:410-25.
4. Weaver DL. Sentinel lymph nodes and breast carcinoma: which micrometastases are clinically significant? Am J Surg Pathol 2003;27:842-5.
5. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymphnode resection and conventional axillarylymphnode dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007;8:881-8.
6. Weaver DL, Krag DN, Ashikaga T, Harlow SP, O'Connell MJ. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer 2000;88:1099-107.
7. Weaver DL, Le UP, Dupuis SL, et al. Metastasis detection in sentinel lymph nodes: comparison of a limited widely spaced (NSABP protocol B-32) and a comprehensive narrowly spaced paraffin block sectioning strategy. Am J Surg Pathol 2009;33:1583-9.
8. Weaver DL. Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale. Mod Pathol 2010;23:Suppl:S26-S32.
9. Greene FL, Page DL, Fleming ID, et al., eds. AJCC cancer staging manual. 6th ed. New York: Springer, 2002.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
11. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
12. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-220.
13. Gibbons JD. Nonparametric statistical inference. New York: McGraw-Hill, 1971.
14. Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymphnode dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010;11:927-33.
15. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-20.
16. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7. (Pubitemid 19032001)
17. Chen SL, Hoehne FM, Giuliano AE. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol 2007;14:3378-84.
18. Cote R, Giuliano AE, Hawes D, et al. ACOSOG Z0010: a multicenter prognostic study of sentinel node (SN) and bone marrow (BM) micrometastases in women with clinical T1/T2 N0 M0 breast cancer. J Clin Oncol 2010;28:Suppl:18. abstract.